Valuation check: EDSA's profit margin is -20511.06%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
As of the most recent data (March 2026), EDSA shows a profit margin of -20511.06%. That is below the Healthcare sector average of 14.34%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average profit margin is about 14.34%. Edesa Biotech is at -20511.06%, which is lower that average. That is roughly 143086.2% below the sector mean. Use the comparison chart on this page to see how EDSA stacks up against individual peers as well.
Check the historical chart to see whether EDSA's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Edesa Biotech with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Edesa Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -20511.06%) with ownership activity and broader fundamentals.
The Healthcare average profit margin is about 14.34%, while EDSA is at -20511.06%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.